Gut microbiome characteristics in individuals across different stages of schizophrenia spectrum disorders: A systematic review and meta-analysis DOI
Li Kong, Xingsong Wang, Guanlin Chen

et al.

Neuroscience & Biobehavioral Reviews, Journal Year: 2025, Volume and Issue: unknown, P. 106167 - 106167

Published: April 1, 2025

Language: Английский

Gut microbiota in chronic obstructive pulmonary disease varies by CT-verified emphysema status DOI Creative Commons
Anders Ørskov Rotevatn, Tomas Eagan, Solveig Tangedal

et al.

European Clinical Respiratory Journal, Journal Year: 2025, Volume and Issue: 12(1)

Published: Feb. 26, 2025

Background and aim The association of the gut microbiota to chronic obstructive pulmonary disease (COPD) phenotypes is underexplored. We aimed compare stool samples from patients with COPD subjects without relate findings emphysema status, exacerbation rate, blood eosinophil levels, symptom score, lung function.

Language: Английский

Citations

1

Translational perspectives of endocrine alterations in psychosis: Are we there yet? DOI
Błażej Misiak, Javier Labad

Psychoneuroendocrinology, Journal Year: 2025, Volume and Issue: 176, P. 107419 - 107419

Published: March 5, 2025

Language: Английский

Citations

0

Effects of GLP-1 Analogues and Agonists on the Gut Microbiota: A Systematic Review DOI Open Access

Krzysztof Gofron,

Andrzej Wasilewski, Sylwia Małgorzewicz

et al.

Nutrients, Journal Year: 2025, Volume and Issue: 17(8), P. 1303 - 1303

Published: April 9, 2025

Background: GLP-1 analogues are a relatively new class of medications that form the cornerstone diabetes treatment. They possess invaluable glucose-lowering properties without hypoglycemic effects as well strong cardioprotective effects. The gut microbiome has become focus numerous studies, demonstrating its influence not only on but also overall well-being entire body. However, analogs microbiota remain uncertain. Scope review: Our systematic review (based PRISMA guidelines) aimed to gather knowledge analogue composition, richness, and abundance in both animal human models. Conclusions: Thirty-eight studies were included this review. have demonstrated notable impact diversity microbiota. We can conclude, following obtained research results our study, liraglutide promotes growth beneficial genera relevant for metabolic functions. Exenatide exendin-4 administration showed various composition studies. In models, it increased associated with improved metabolism; however, linked better functions escalated inflammation increased. Following dulaglutide administration, increases Bacteroides, Akkermansia, Ruminococcus, connected an model, significant. Finally, varied after semaglutide treatment, which A. muciniphila, known positive functions, increased; microbial decreased. Semaglutide treatment provided indicating many confounding factors semaglutide’s Results due dissimilarities studied populations duration Further is essential confirm these findings recognize their implications clinical outcomes patients.

Language: Английский

Citations

0

Gut microbiome characteristics in individuals across different stages of schizophrenia spectrum disorders: A systematic review and meta-analysis DOI
Li Kong, Xingsong Wang, Guanlin Chen

et al.

Neuroscience & Biobehavioral Reviews, Journal Year: 2025, Volume and Issue: unknown, P. 106167 - 106167

Published: April 1, 2025

Language: Английский

Citations

0